Order Information
Contact us
Insert title here
Featured Products
HY-10087  |  Navitoclax
HY-10128  |  ZM-447439
HY-10161  |  Tozasertib
HY-10180  |  MLN8054
HY-10192  |  NVP-TAE 684
HY-10249  |  GSK-690693
HY-10355  |  AKT inhibitor VIII
HY-10358  |  MK 2206 (dihydrochloride)
HY-11002  |  CP-466722
HY-11007  |  GNF-2
HY-50662  |  A-769662
HY-50907  |  ABT-737
HY-70061  |  Aurora A inhibitor I
Products |  Featured Products
Cat.No. Product Name / Activity Added
HY-10087 Navitoclax August 2017
Navitoclax is a potent and orally bioavailable <b>Bcl-2 family protein</b> inhibitor that binds with high affinity (<b>K<sub>i</sub></b> < 1 nM) to multiple anti-apoptotic Bcl-2 family proteins including Bcl-x<sub>L</sub>, Bcl-2 and Bcl-w.
HY-10128 ZM-447439 August 2017
ZM 447439 is a selective and ATP-competitive inhibitor for Aurora A and Aurora B with IC50 of 110 nM, 130 nM respectively, > 8 fold selectivity than Aurora C, MEK1, Src.
HY-10161 Tozasertib August 2017
Tozasertib is the inhibitor of <b>Aurora-A, -B, -C kinases</b> with <b>K<sub>i</sub></b> values of 0.
HY-10180 MLN8054 August 2017
MLN8054 is a potent and selective inhibitor of Aurora A with IC50 of 4 nM; exhibits more than 40-fold selective for Aurora A than Aurora B.
HY-10192 NVP-TAE 684 August 2017
NVP-TAE 684 is a highly potent and selective <b>ALK</b> inhibitor, which blocks the growth of ALCL-derived and ALK-dependent cell lines with <b>IC<sub>50</sub></b> values between 2 and 10 nM.
HY-10249 GSK-690693 August 2017
GSK-690693 is a pan-Akt inhibitor targeting?<b>Akt1/2/3</b>?with?<b>IC<sub>50</sub></b>?of 2/13/9 nM in cell-free assays, also sensitive to the AGC kinase family: PKA, PrkX and PKC isozymes.
HY-10355 AKT inhibitor VIII August 2017
AKT inhibitor VIII is a cell-permeable quinoxaline compound that has been shown to potently, selectively, allosterically, and reversibly inhibit <b>Akt1</b>, <b>Akt2</b>, and <b>Akt3</b> activity with <b>IC<sub>50</sub></b>s of 58 nM, 210 nM, and 2.
HY-10358 MK 2206 (dihydrochloride) August 2017
MK 2206 is an orally active allosteric <b>Akt</b> inhibitor with <b>IC<sub>50</sub></b> of 5 nM/12 nM/65 nM for <b>Akt1/2/3</b>, respectively.
HY-11002 CP-466722 August 2017
CP-466722 is rapidly reversible potential ATM kinase inhibitor.
HY-11007 GNF-2 August 2017
GNF-2 is a highly selective non-ATP competitive inhibitor of oncogenic Bcr-Abl activity (IC50 = 0.
HY-50662 A-769662 August 2017
A-769662 is a potent, reversible <b>AMPK</b> activator with EC<sub>50</sub> of 0.
HY-50907 ABT-737 August 2017
ABT-737 is a BH3 mimetic inhibitor of?<b>Bcl-xL</b>,?<b>Bcl-2</b>?and?<b>Bcl-w</b>?with?<b>EC<sub>50</sub></b>?of 78.
HY-70061 Aurora A inhibitor I August 2017
Aurora A inhibitor I is a selective Aurora A inhibitor (Aurora A: IC50=0.
Insert title here
Products are for research use only. Not for human use. We do not sell to patients.           Copyright © 2009 Haoyuan Chemexpress All Rights Reserved
ADDRESS: 6/F, No. 2 Building, No. 720,Cailun Road, Shanghai, P.R.China  
86-21-58998590   FAX: 86-21-53700326, 86-21-58998590   E-mail: sales@chemexpress.cn